Impaired sleep is associated with inflammatory activity in inflammatory bowel disease (IBD), but not symptoms.

Women with cardiovascular disease (CVD) have a substantially higher adiposity-associated risk for breast cancer.

Sleep disorders contribute to mental health challenges, traumatic injuries, and increased health care utilization in active-duty service members.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.